(Q24806597)

3

object named as

Efstathios Stathopoulos

0 references

author name string

Nikos Tsakountakis

1

0 references

Elias Sanidas

2

0 references

Maria Kafousi

4

0 references

Nektaria Anogiannaki

5

0 references

Vasilis Georgoulias

6

0 references

Dimitris D Tsiftsis

Epidemiology of endocrine-related risk factors for breast cancer

7

0 references

publication date

4 February 2005

0 references

published in

BMC Women's Health

0 references

volume

5

0 references

issue

1

0 references

page(s)

1

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549187

Steroid receptors in human breast tumorigenesis and breast cancer progression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549187

Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549187

Hormonal control of growth factor receptor expression.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549187

Oncogenes, breast cancer, and chemoprevention.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549187

The neu-oncogene: more than a prognostic indicator?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549187

17 beta-estradiol mimics ligand activity of the c-erbB2 protooncogene product

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549187

Mitogenic regulation of normal and malignant breast epithelium

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549187

Genetic alterations in primary breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549187

The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549187

Her-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549187

Immunohistochemical detection of HER2/neu in patients with axillary lymph node negative breast carcinoma. A study of epidemiologic risk factors, histologic features, and prognosis.

30 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1472-6874-5-1

Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1472-6874-5-1

Risk of breast cancer according to the status of HER-2/neu oncogene amplification.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549187

Statistical analysis of molecular epidemiology studies employing case-series.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549187

The epidemiology of serum sex hormones in postmenopausal women

28 November 2018

1 reference

12 December 2020

Differences in breast cancer risk factors to neu (c-erbB-2) protein overexpression of the breast tumor

1 reference

12 December 2020

Incidence of breast cancer on Crete, 1994-1995

1 reference

12 December 2020

Correlation of HER-2/neu amplification with expression and with other prognostic factors in 1103 breast cancers

1 reference

12 December 2020

c-erbB-2 positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease

1 reference

12 December 2020

Genetic alterations in ERBB2-amplified breast carcinomas

1 reference

12 December 2020

Dimensions Publication ID

Identifiers

DOI

10.1186/1472-6874-5-1

0 references

1031213643

0 references

Fatcat ID

release_v3ohnpqqejgs3mewiwzqkmiciq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/v3ohnpqqejgs3mewiwzqkmiciq

24 November 2022